Locations:
Search IconSearch

Cleveland Clinic Performs World’s First DBS Surgery for Stroke Recovery

Patient doing well, stimulation to start in coming weeks

twitter-170104-17-neu-504-machado-650×450

Cleveland Clinic has performed the first deep brain stimulation (DBS) surgery in a patient for the purpose of restoring motor function following ischemic stroke.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

During a six-hour procedure on Dec. 19, 2016, a team led by Andre Machado, MD, PhD, implanted DBS electrodes in the cerebellum of the patient, who has severe post-stroke residual hemiparesis despite previous physical therapy. The patient has been discharged home feeling well and in stable condition.

Over the next few weeks, following adequate healing and recovery from the brain surgery, the patient will undergo physical therapy. After a few weeks of rehabilitation, the DBS device connected to the implanted electrodes will be turned on as the patient continues physical therapy. The patient will be monitored and evaluated regularly to determine whether and how DBS can enhance the effects of physical therapy.

The first-in-human operation is the initial case in an NIH-supported Cleveland Clinic trial of DBS for stroke recovery detailed previously on Consult QD.

“If this research succeeds, it is a new hope for patients who have remained paralyzed after a stroke,” says Dr. Machado, Chairman of Cleveland Clinic’s Neurological Institute and a neurosurgeon specializing in neuromodulation. “It is an opportunity to allow our patients to rehabilitate and gain function and independence. Our knowledge to date shows that deep brain stimulation can help the brain reorganize and adapt beyond what physical therapy alone can do. Our study’s goal is to boost rehabilitation outcomes beyond what physical therapy alone could achieve.”

More details about this initial case in the trial are available in a new Time magazine feature. Dr. Machado (shown in the foreground of the above photo) discusses the trial’s rationale and goals in this short Consult QD video.

Advertisement

Related Articles

Physical therapist helping patient walk with a powered exoskeleton and walker

Exoskeleton-Aided Physical Therapy Proves Feasible in MS

Study looked at mobility measures and safety

portrait of Dr. Kriti Bhayana against decorative background with podcast overlay
April 2, 2026/Neurosciences/Podcast

Practice Essentials for Pediatric and Perinatal Stroke (Podcast)

Types and presentation may differ from adults, but early recognition and intervention are just as key

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

Ad